Uhlin Fredrik, Magnusson Per, Larsson Tobias E, Fernström Anders
Clin Nephrol. 2015 Jun;83(6):315-21. doi: 10.5414/CN108468.
BACKGROUND/AIMS: Vitamin D deficiency and elevated serum fibroblast growth factor-23 (FGF23) levels are hallmark features and surrogate markers of adverse clinical outcomes in patients with chronic kidney disease (CKD). Convection of molecules over the dialysis membrane during online hemodiafiltration (ol-HDF) increases the removal of larger waste molecules compared with traditional high-flux hemodialysis (HD). The primary aim of this study was to explore the long-term impact of ol-HDF on serum 25(OH)D and FGF23.
An observational, prospective, noncomparator study including 35 patients who were switched from HD to ol-HDF. Serum 25(OH)D and FGF23 were measured at baseline (i.e., time of switch to ol-HDF) and at 6, 12, and 24 months.
At follow-up time points, there was a significant reduction in serum 25(OH)D compared with baseline (p<0.0001) whereas FGF23 was unaltered (p>0.05). The decrease in 25(OH)D was more prominent in individuals with higher baseline 25(OH)D levels.
Ol-HDF may lower systemic 25(OH)D levels by convective mechanisms although the clinical significance remains unknown. Further controlled studies are warranted to replicate these findings in larger patient cohorts.
背景/目的:维生素D缺乏和血清成纤维细胞生长因子23(FGF23)水平升高是慢性肾脏病(CKD)患者不良临床结局的标志性特征和替代标志物。与传统高通量血液透析(HD)相比,在线血液透析滤过(ol-HDF)期间透析膜上分子的对流增加了对较大废物分子的清除。本研究的主要目的是探讨ol-HDF对血清25(OH)D和FGF23的长期影响。
一项观察性、前瞻性、非对照研究,纳入35例从HD转换为ol-HDF的患者。在基线(即转换为ol-HDF时)以及6、12和24个月时测量血清25(OH)D和FGF23。
在随访时间点,与基线相比,血清25(OH)D显著降低(p<0.0001),而FGF23未改变(p>0.05)。25(OH)D的降低在基线25(OH)D水平较高的个体中更为明显。
ol-HDF可能通过对流机制降低全身25(OH)D水平,但其临床意义尚不清楚。有必要进行进一步的对照研究,以在更大的患者队列中重复这些发现。